Analysts Set Genesee & Wyoming Inc (GWR) Price Target at $85.75

Share on StockTwits

Shares of Genesee & Wyoming Inc (NYSE:GWR) have received an average rating of “Hold” from the fourteen analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, eight have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $85.75.

Several research firms have recently weighed in on GWR. ValuEngine raised shares of Genesee & Wyoming from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. Morgan Stanley raised their price target on shares of Genesee & Wyoming from $79.00 to $81.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 9th. Zacks Investment Research raised shares of Genesee & Wyoming from a “hold” rating to a “buy” rating and set a $99.00 price target on the stock in a research note on Monday, August 6th. Bank of America downgraded shares of Genesee & Wyoming from a “buy” rating to a “neutral” rating and raised their price target for the stock from $90.00 to $94.00 in a research note on Thursday, August 9th. Finally, Wolfe Research downgraded shares of Genesee & Wyoming from an “outperform” rating to a “market perform” rating in a research note on Monday, July 30th.

In other Genesee & Wyoming news, insider Christopher F. Liucci sold 1,137 shares of Genesee & Wyoming stock in a transaction dated Wednesday, August 29th. The shares were sold at an average price of $89.25, for a total transaction of $101,477.25. Following the transaction, the insider now directly owns 19,326 shares of the company’s stock, valued at $1,724,845.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO David A. Brown sold 3,429 shares of Genesee & Wyoming stock in a transaction dated Wednesday, August 29th. The stock was sold at an average price of $87.98, for a total transaction of $301,683.42. Following the transaction, the chief operating officer now directly owns 33,938 shares in the company, valued at $2,985,865.24. The disclosure for this sale can be found here. Insiders have sold 18,139 shares of company stock worth $1,597,699 over the last ninety days. 2.41% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of the business. Institute for Wealth Management LLC. raised its stake in Genesee & Wyoming by 4.6% during the second quarter. Institute for Wealth Management LLC. now owns 13,280 shares of the transportation company’s stock worth $1,075,000 after purchasing an additional 581 shares during the period. Oregon Public Employees Retirement Fund raised its stake in Genesee & Wyoming by 3.0% during the second quarter. Oregon Public Employees Retirement Fund now owns 23,770 shares of the transportation company’s stock worth $1,933,000 after purchasing an additional 687 shares during the period. Jacobs & Co. CA raised its stake in Genesee & Wyoming by 3.0% during the second quarter. Jacobs & Co. CA now owns 25,032 shares of the transportation company’s stock worth $2,035,000 after purchasing an additional 730 shares during the period. Mutual of America Capital Management LLC raised its stake in Genesee & Wyoming by 1.4% during the second quarter. Mutual of America Capital Management LLC now owns 51,726 shares of the transportation company’s stock worth $4,206,000 after purchasing an additional 739 shares during the period. Finally, Xact Kapitalforvaltning AB raised its stake in Genesee & Wyoming by 21.8% during the first quarter. Xact Kapitalforvaltning AB now owns 5,030 shares of the transportation company’s stock worth $356,000 after purchasing an additional 900 shares during the period. 92.20% of the stock is currently owned by institutional investors.

Shares of NYSE:GWR traded down $0.23 during midday trading on Thursday, hitting $79.00. The company’s stock had a trading volume of 407,118 shares, compared to its average volume of 512,178. The company has a current ratio of 1.33, a quick ratio of 1.22 and a debt-to-equity ratio of 0.61. The company has a market cap of $4.87 billion, a P/E ratio of 27.15, a P/E/G ratio of 1.20 and a beta of 1.71. Genesee & Wyoming has a 12-month low of $67.61 and a 12-month high of $92.91.

Genesee & Wyoming (NYSE:GWR) last posted its quarterly earnings results on Tuesday, October 30th. The transportation company reported $1.23 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.07. The firm had revenue of $603.30 million for the quarter, compared to the consensus estimate of $594.40 million. Genesee & Wyoming had a net margin of 26.25% and a return on equity of 5.81%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period last year, the firm posted $0.81 earnings per share. On average, analysts expect that Genesee & Wyoming will post 3.85 earnings per share for the current year.

Genesee & Wyoming Company Profile

Genesee & Wyoming Inc owns and leases freight railroads. It operates through three segments: North American Operations, Australian Operations, and U.K./European Operations. The company transports various commodities, including agricultural products, autos and auto parts, chemicals and plastics, coal and coke, food and kindred products, lumber and forest products, metallic ores, metals, minerals and stone, petroleum products, pulp and paper, waste, and other commodities.

See Also: Stock Selection – What is cash flow?

Analyst Recommendations for Genesee & Wyoming (NYSE:GWR)

Receive News & Ratings for Genesee & Wyoming Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesee & Wyoming and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.